Congressional trades by ticker
GSK congressional trades
- Verified rows
- 11
- Filers
- 4
- Purchases
- 5
- Latest trade
- 2025-10-31
Verified GSK House disclosures
Parsed from official House Clerk periodic transaction reports. This snapshot contains 5 purchases and 6 sales. Reported owners: Spouse, Self. Transaction dates run from 2024-11-18 to 2025-10-31.
| Politician | Trade date | Asset | Type | Owner | Amount | Filing |
|---|---|---|---|---|---|---|
| Lisa McClain | GSK plc American Depositary Shares | Sale | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Lisa McClain | GSK plc American Depositary Shares | Purchase | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Lisa McClain | GSK plc American Depositary Shares | Sale | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Valerie Hoyle | GSK plc American Depositary Shares | Sale | Spouse | $1,001 - $15,000 | #20032211 Filed 2025-10-10 | |
| Lisa McClain | GSK plc American Depositary Shares | Purchase | Spouse | $1,001 - $15,000 | #20030932 Filed 2025-09-12 | |
| Robert Aderholt | GSK plc American Depositary Shares | Sale | Self | $1,001 - $15,000 | #20032062 Filed 2025-09-10 | |
| Lisa McClain | GSK plc American Depositary Shares | Sale | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Lisa McClain | GSK plc American Depositary Shares | Purchase | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Bruce Westerman | GSK plc American Depositary Shares | Sale | Self | $1,001 - $15,000 | #20030332 Filed 2025-05-12 | |
| Bruce Westerman | GSK plc American Depositary Shares | Purchase | Self | $1,001 - $15,000 | #20030146 Filed 2025-04-16 | |
| Valerie Hoyle | GSK plc American Depositary Shares | Purchase | Spouse | $1,001 - $15,000 | #20032070 Filed 2025-09-12 |
A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.
The filing is free
Keep the GSK range and owner as filed. Membership adds the investment view around the money, not a list to copy.
Related research
GSK congressional trades — FAQ
Who in Congress traded GSK?
House Clerk periodic reports for 2025 and 2026 contain 11 verified GSK rows from 4 members: Bruce Westerman, Lisa McClain, Robert Aderholt, and Valerie Hoyle. Image-only filings are excluded, and this is not a live brokerage statement.
Does this page show current GSK holdings?
No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.
Why are GSK amounts shown as ranges?
House periodic transaction reports use statutory value bands such as $1,001 - $15,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.
How complete is GSK congressional-trade coverage?
This snapshot covers every machine-readable House periodic transaction report for 2025 and 2026 (142 members). Image-only filings and Senate eFD filings are not included, so missing rows are not proof that no other lawmaker traded GSK.
Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk periodic report snapshot generated 2026-09-20. It is not a complete lifetime portfolio, a performance track record, or investment advice.
A disclosure is not a thesis.
This page shows who reported GSK and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $15/month or $150/year.
$15/mo or $150/yr · cancel future renewals anytime · sources included